Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents
Author:
Affiliation:
1. School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
Funder
Southern Medical University
Organization Department of the Central Committee of the Communist Party of China
Guangdong Province
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00413
Reference80 articles.
1. Transgenerational epigenetic inheritance: an open discussion
2. Epigenetic linkage of aging, cancer and nutrition
3. Manipulating macrophage polarization and function using classical HDAC inhibitors: Implications for autoimmunity and inflammation
4. Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics
5. New and emerging HDAC inhibitors for cancer treatment
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress;Cancer Letters;2024-02
2. Near‐Infrared Light‐Driven Nanoparticles for Cancer Photoimmunotherapy by Synergizing Immune Cell Death and Epigenetic Regulation;Small;2023-12-15
3. A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy;European Journal of Medicinal Chemistry;2023-11
4. Synthesis and bioevaluation of novel stilbene-based derivatives as tubulin/HDAC dual-target inhibitors with potent antitumor activities in vitro and in vivo;European Journal of Medicinal Chemistry;2023-09
5. Discovery of chiral 1,4-diarylazetidin-2-one-based hydroxamic acid derivatives as novel tubulin polymerization inhibitors with histone deacetylase inhibitory activity;Bioorganic & Medicinal Chemistry;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3